Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-27T07:53:06.349Z Has data issue: false hasContentIssue false
  • English
  • Français

EU Initiative to Tackle Medication Errors – Proposals and Challenges

Published online by Cambridge University Press:  20 January 2017

Els Janssens
Els Janssens*
Affiliation:
European Medicines Agency
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Reports
Information
European Journal of Risk Regulation , Volume 4 , Issue 3 , September 2013 , pp. 388 - 391
Copyright
Copyright © Cambridge University Press 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 EMA press release of 1 march 2013 (EMA/130601/2013).

2 EMA medication errors workshop report -<http://www.ema.europa.eu/docs/en_GB/document_library/Report/2013/05/WC500143163.pdf>.

3 Lisby, M., Nielsen, L.P., Brock, B. and Mainz, J., “How are medication errors defined? A systematic literature review of definitions and characteristics”, 22(6) International Journal for quality in healthcare (2010), pp. 507–518 CrossRefGoogle ScholarPubMed (Advance Access Publication: 17 October 2010), as quoted by Jeffrey Aronson and Robin Ferner in their presentation “Do we have a common understanding of medication errors?” during EMA workshop on medication errors on 28 February 2013.

4 Ferner, R. and Aronson, J., “Clarification of terminology in medication errors – Definitions and classification”, 29(11) Drug Safety (2006), 1011–1022 CrossRefGoogle ScholarPubMed.

5 Directive 2010/84/EU of the European Parliament and of the Council of 15 December 2010 amending as regards pharmacovigilance, Directive 2001/83/EC on the Community Code relating to medicinal products for human use (Official Journal L 348, 31/12/2010, p. 74-99).

6 Position paper on potential medication errors in the context of benefit risk balance and risk minimisation measures, 30 May 2013 (EMA/277591/2013).

7 Council Recommendation of 9 June 2009 on patient safety, including the prevention and control of healthcare associated infections (2009/C 151/01).

8 Report from the Commission to the Council on the basis of Member States’ reports on the implementation of the Council Recommendation (2009/C 151/01) on patient safety, including the prevention and control of healthcare associated infections (COM(2012) 658 final)

9 Directive 2001/83/EC and Regulation (EC) No 726/2004

10 Report from the Commission to the Council on the basis of Member States’ reports on the implementation of the Council Recommendation (2009/C 151/01) on patient safety, including the prevention and control of healthcare associated infections (COM(2012) 658 final)

11 Wachter, R and Pronovost, P., “Balancing “No Blame” with accountability in patient safety”, 361(14) The New England Journal of Medicine (2009), pp. 1401–1406 CrossRefGoogle ScholarPubMed